Prognosis of biopsy-confirmed MASLD: a sub-analysis of the CLIONE study
CONCLUSIONS: Approximately 99% of NAFLD cases corresponded to MASLD. NAFLD only group, which is not included in MASLD, had relatively mild histopathologic severity and a favorable prognosis. Consequently, the prognosis of MASLD was similar to that of NAFLD.PMID:38263684 | DOI:10.3350/cmh.2023.0515
Source: Clinical and molecular hepatology - Category: Gastroenterology Authors: Michihiro Iwaki Hideki Fujii Hideki Hayashi Hidenori Toyoda Satoshi Oeda Hideyuki Hyogo Miwa Kawanaka Asahiro Morishita Kensuke Munekage Kazuhito Kawata Tsubasa Tsutsumi Koji Sawada Tatsuji Maeshiro Hiroshi Tobita Yuichi Yoshida Masafumi Naito Asuka Araki Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Fatty Liver Disease (FLD) | Gastroenterology | Heart | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Transplants | Urology & Nephrology